Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials-Reference-Cited by-同舟云学术

Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials

Published:2022-07 Issue:7 Volume:24 Page:742-749
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Stewart Mark D.^ORCID,McCall Bruce,Pasquini Marcelo^ORCID,Yang Allen S.,Britten Carolyn D.,Chuk Meredith,De Claro R Angelo,George Bindu,Gormley Nicole,Horowitz Mary M.,Kowack Eric,McCoy Candice,Morrow Phuong Khanh,Okoye Emmanuel,Ricafort Rosanna,Rossi John,Sharon Elad^ORCID,Theoret Marc^ORCID,Vegni Ferdinando,Yu Tai,Allen Jeff^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference24 articles.

1. Immuno-oncology drug development goes global;Xin Yu;Nature reviews. Drug discovery,2019

2. Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies;Khadka;Immunotherapy,2019

3. Cytokine Release Syndrome: Current Perspectives;Murthy;ImmunoTargets Ther,2019

4. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events;Maus;J. Immunother. cancer,2020

5. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline;Santomasso;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy;Frontiers in Medicine;2024-01-03

2. rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses;Journal of Experimental & Clinical Cancer Research;2023-07-12